China Money Network
Login
Join

Chinese Biopharma Firm Asieris Completes RMB700M Round

  • November 12, 2020 — 07:27 CST

This Data Is Locked!

This area is available only to Subscribers.

Asieris Pharmaceuticals is a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases.... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: